Exact Mass: 562.2333324
Exact Mass Matches: 562.2333324
Found 161 metabolites which its exact mass value is equals to given mass value 562.2333324
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1-(4-(5-Maleimidopentyl)aminobenzyl)ethylenediaminetetraacetic acid
Baccharinol
3,3-Dihydroxy-5-methoxy-2,5,6-tris(4-hydroxybenzyl)bibenzyl
(2S,3R,4S,7R,9R,10S)-7-Deoxo-2-deoxy-2,3:9,10-diepoxy-9,10-dihydro-4-hydroxy-7-[(1R)-1-hydroxyethyl]verrucarin A
(19Z)-burnamine-17-O-3,4,5-trimethoxybenzoate|19(Z)-burnamine-17-O-3,4,5-trimethoxybenzoate|burnamine-17-O-3,4,5-trimethoxybenzoate
C31H34N2O8 (562.2315044000001)
(20R,22R)-15alpha-acetoxy-5alpha-chloro-16beta,17beta-epoxy-6beta,14beta-dihydroxy-1-oxo-witha-2,24-dienolide|physagulin I
1beta-(p-hydroxyphenylacetyl)-15-O-beta-D-glucopyranosyl-5alpha,6betaH-eudesma-3-en-12,6alpha-olide
3,3-dihydroxy-5-methoxy-2,6,6-tri(p-hydroxybenzyl)bibenzyl|pleiobibenzynin A
9-O-butyl-3-O-demethyl-9-O-beta-D-glucopyranosyldehydrodiconiferyl alcohol
(5S)-1,7-bis-(3,4-dihydroxyphenyl)-5-hydroxy-3-heptanone-5-O-[2-(2-methylbutenoyl)]-beta-D-xylopyranoside|alnuside C
3,3-dihydroxy-5-methoxy-2,4,6-tri(4-hydroxybenzyl)bibenzyl
Ala Phe Tyr Tyr
Ala Tyr Phe Tyr
Ala Tyr Tyr Phe
Cys Phe Phe Phe
Asp Asp Lys Trp
Asp Asp Trp Lys
Asp Lys Asp Trp
Asp Lys Trp Asp
Asp Trp Asp Lys
Asp Trp Lys Asp
Glu Gln Thr Trp
Glu Gln Trp Thr
Glu Thr Gln Trp
Glu Thr Trp Gln
Glu Trp Gln Thr
Glu Trp Thr Gln
Phe Ala Tyr Tyr
Phe Cys Phe Phe
Phe Phe Cys Phe
Phe Phe Phe Cys
Phe Phe Ser Tyr
Phe Phe Tyr Ser
Phe Ser Phe Tyr
Phe Ser Tyr Phe
Phe Tyr Ala Tyr
Phe Tyr Phe Ser
Phe Tyr Ser Phe
Phe Tyr Tyr Ala
Lys Asp Asp Trp
Lys Asp Trp Asp
Lys Trp Asp Asp
Gln Glu Thr Trp
Gln Glu Trp Thr
Gln Thr Glu Trp
Gln Thr Trp Glu
Gln Trp Glu Thr
Gln Trp Thr Glu
Ser Phe Phe Tyr
Ser Phe Tyr Phe
Ser Tyr Phe Phe
Thr Glu Gln Trp
Thr Glu Trp Gln
Thr Gln Glu Trp
Thr Gln Trp Glu
Thr Trp Glu Gln
Thr Trp Gln Glu
Trp Asp Asp Lys
Trp Asp Lys Asp
Trp Glu Gln Thr
Trp Glu Thr Gln
Trp Lys Asp Asp
Trp Gln Glu Thr
Trp Gln Thr Glu
Trp Thr Glu Gln
Trp Thr Gln Glu
Tyr Ala Phe Tyr
Tyr Ala Tyr Phe
Tyr Phe Ala Tyr
Tyr Phe Phe Ser
Tyr Phe Ser Phe
Tyr Phe Tyr Ala
Tyr Ser Phe Phe
Tyr Tyr Ala Phe
Tyr Tyr Phe Ala
Otilonium Bromide
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D005765 - Gastrointestinal Agents Otilonium bromide (OB) is an orally active mAChR inhibitor and smooth muscle relaxant which can interfere with the mobilization of calcium in intestinal smooth muscle, OB can be used for research of irritable bowel syndrome[1][2][3].
Zinc,bis[3,5-bis(1,1-dimethylethyl)-2-(hydroxy-kO)benzoato-kO]-, (T-4)-
Flumatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-[(2R,4R)-2-(4-hydroxybutoxy)-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyran-6-yl]methanone
C29H33F3N2O6 (562.2290594000001)
[(1S)-7-methoxy-1-(4-methoxyphenyl)sulfonyl-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
[(1R)-7-methoxy-1-(4-methoxyphenyl)sulfonyl-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
SCH529074
SCH529074 is a potent and orally active p53 activator. SCH529074 binds specifically and conformation-dependently to p53 DBD ( DNA binding domain) with a Ki of 1-2 μM in a saturable manner. SCH529074 restores mutant p53 function and interrupts HDM2-mediated ubiquitination of wild Type p53. SCH529074 can be used for the study of non-small-cell lung carcinoma (NSCLC)[1][2].
(3r,6z,10s,14z,19r,22s,23s,26r,29r)-1,22,29-trihydroxy-10-(2-hydroxyacetyl)-2,22-dimethyl-4,11,17,25-tetraoxahexacyclo[21.3.1.1³,²⁶.1¹⁰,¹⁴.0²,¹⁹.0¹⁹,²⁴]nonacosa-6,14-diene-5,16-dione
3-[2-(3-hydroxyphenyl)ethyl]-2,4,6-tris[(4-hydroxyphenyl)methyl]-5-methoxyphenol
5-[(2r,3s)-7-hydroxy-2-(hydroxymethyl)-4-(prop-2-en-1-yl)-6-[4-(prop-2-en-1-yl)phenoxy]-2,3-dihydro-1-benzofuran-3-yl]-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol
(4s,10s,11s,13s,14s,16r,17s,18r,21s,24s)-24-(acetyloxy)-9,9,13,16,17,21-hexamethyl-7,19-dioxo-2,8,20,22,23-pentaoxahexacyclo[12.8.1.1¹⁸,²¹.0¹,¹⁶.0⁴,¹⁰.0⁴,¹⁴]tetracos-5-en-11-yl acetate
(1r,8r,9s,10r,11r,13r,14s,15s,18s,24r,26s,27r)-10,15,26,27-tetrahydroxy-9,15-dimethyl-7,12,20,25,28-pentaoxaheptacyclo[21.4.3.1⁸,¹¹.1¹⁰,¹⁴.0¹,²⁴.0⁹,¹⁸.0¹³,¹⁸]dotriaconta-4,22-diene-6,21-dione
(1r,5s,7s,8r,11r,12z,14e,18s,20r,22s,23s,25r,28r)-8-hydroxy-11-[(1s)-1-hydroxyethyl]-7,25,28-trimethyl-20-[(2r)-oxiran-2-yl]-3,6,10,17,21,24-hexaoxahexacyclo[16.9.1.0¹,²².0⁵,⁷.0²⁰,²⁸.0²³,²⁵]octacosa-12,14-diene-4,16-dione
methyl 5-methoxy-12-[1-(7-methoxy-2h-1,3-benzodioxole-5-carbonyloxy)ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C31H34N2O8 (562.2315044000001)
10,15,26,27-tetrahydroxy-9,15-dimethyl-7,12,20,25,28-pentaoxaheptacyclo[21.4.3.1⁸,¹¹.1¹⁰,¹⁴.0¹,²⁴.0⁹,¹⁸.0¹³,¹⁸]dotriaconta-4,22-diene-6,21-dione
alnuside c
{"Ingredient_id": "HBIN015275","Ingredient_name": "alnuside c","Alias": "NA","Ingredient_formula": "C29H38O11","Ingredient_Smile": "CCC(C)C(=O)OC1C(C(COC1OC(CCC2=CC(=C(C=C2)O)O)CC(=O)CCC3=CC(=C(C=C3)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "961","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
baccharin
{"Ingredient_id": "HBIN017488","Ingredient_name": "baccharin","Alias": "NA","Ingredient_formula": "C29H38O11","Ingredient_Smile": "CC(C1C=CC=CC(=O)OC2CC3C4(C2(C5(CCC6(C(C5O3)O6)C)COC(=O)C7C(O7)(C(CO1)O)C)C)CO4)O","Ingredient_weight": "562.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6442;20997","PubChem_id": "117587576","DrugBank_id": "NA"}
methyl (3s)-3-(acetyloxy)-3-[(1r,2r,5r,6r,7r,8s,10s,11s,14s)-11-(furan-3-yl)-8-hydroxy-5-(2-hydroxypropan-2-yl)-2,6,10-trimethyl-3,13-dioxo-12,15-dioxatetracyclo[8.5.0.0¹,¹⁴.0²,⁷]pentadecan-6-yl]propanoate
methyl 14-ethylidene-19-[(3,4,5-trimethoxybenzoyloxy)methyl]-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
C31H34N2O8 (562.2315044000001)
5-[7-hydroxy-2-(hydroxymethyl)-4-(prop-2-en-1-yl)-6-[4-(prop-2-en-1-yl)phenoxy]-2,3-dihydro-1-benzofuran-3-yl]-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol
(3s,3as,5ar,6r,9as,9bs)-3,5a-dimethyl-2-oxo-9-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-6-yl 2-(4-hydroxyphenyl)acetate
(1s,4as,6s,7r,7as)-4-({[(2r,3r,4s,5s,6r)-3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-[(acetyloxy)methyl]-6,7-dihydroxy-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(1s,4as,6s,7r,7as)-6-(acetyloxy)-7-[(acetyloxy)methyl]-7-hydroxy-4-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
4-({[3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-[(acetyloxy)methyl]-6,7-dihydroxy-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(1s,3r,7r,10s,12s,13r,15s,16s,17s,18s,21r,22s,24r,25s,26s)-12,15,25-trihydroxy-9,9,21,24,26-pentamethyl-4,8,19,23,29-pentaoxaoctacyclo[13.13.1.0¹,¹³.0³,⁷.0³,¹⁰.0¹⁶,²⁶.0¹⁷,²⁴.0¹⁸,²²]nonacosane-5,14,20-trione
3-[1-hydroxy-7-(6-{7-hydroxy-7-[2-hydroxy-5-(hydroxymethyl)-4-oxo-5h-pyrrol-3-ylidene]hepta-1,3,5-trien-1-yl}cyclohex-2-en-1-yl)hepta-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione
C31H34N2O8 (562.2315044000001)
(1s,4as,6s,7r,7as)-6-(acetyloxy)-4-({[(2r,3r,4s,5s,6r)-3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-hydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(1r,2s,3s,4s,6r,7s,10s,11s,16r,17r)-16-chloro-6-[(1r)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,17-dihydroxy-7,11-dimethyl-12-oxo-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadec-13-en-3-yl acetate
(1's,2r,3'r,6'r,12's,14'r,15's,18'r,19'e,21'z,25'r,26's)-6',15'-dihydroxy-18'-[(1r)-1-hydroxyethyl]-5',14',26'-trimethyl-2',10',13',17',24'-pentaoxaspiro[oxirane-2,27'-pentacyclo[23.2.1.0³,⁸.0⁸,²⁶.0¹²,¹⁴]octacosane]-4',19',21'-triene-11',23'-dione
(2s,3r,4s,5r)-2-{[(3s)-1,7-bis(3,4-dihydroxyphenyl)-5-oxoheptan-3-yl]oxy}-4,5-dihydroxyoxan-3-yl (2r)-2-methylbutanoate
methyl (1r,12r,19r)-5-methoxy-12-[(1s)-1-(7-methoxy-2h-1,3-benzodioxole-5-carbonyloxy)ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
C31H34N2O8 (562.2315044000001)
methyl 2-[(1s,3r,4r,5s,7s,8s,9s,10s,11s,12s,16r)-5-(acetyloxy)-12-(furan-3-yl)-4,10-dihydroxy-6,6,8,11,16-pentamethyl-14,17-dioxo-2,13-dioxatetracyclo[7.6.2.0¹,¹¹.0³,⁸]heptadecan-7-yl]acetate
(1s,4as,6s,7r,7as)-6-(acetyloxy)-7-[(acetyloxy)methyl]-7-hydroxy-4-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(1r,3s,7r,8r,10r,11r,12s,14r,15r,18r)-7-{[(2s,3r,4r,6r)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-8,12,18-trihydroxy-10,14-dimethyl-15-(5-oxo-2h-furan-3-yl)-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-5-en-13-one
(8r,9s,10r,11r,13r,14s,15s,18r,24r,26s,27s)-10,15,26,27-tetrahydroxy-9,15-dimethyl-7,12,20,25,28-pentaoxaheptacyclo[21.4.3.1⁸,¹¹.1¹⁰,¹⁴.0¹,²⁴.0⁹,¹⁸.0¹³,¹⁸]dotriaconta-4,22-diene-6,21-dione
3-(2-{5-hydroxy-2-[(4-hydroxyphenyl)methyl]phenyl}ethyl)-2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol
2-{[1,7-bis(3,4-dihydroxyphenyl)-5-oxoheptan-3-yl]oxy}-4,5-dihydroxyoxan-3-yl 2-methylbutanoate
7-[(3,4-dihydroxy-6-methyloxan-2-yl)oxy]-8,12,18-trihydroxy-10,14-dimethyl-15-(5-oxo-2h-furan-3-yl)-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-5-en-13-one
methyl (1r,9s,11s,15s,17s,19r)-14-ethylidene-19-[(3,4,5-trimethoxybenzoyloxy)methyl]-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
C31H34N2O8 (562.2315044000001)
16-chloro-6-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-2,17-dihydroxy-7,11-dimethyl-12-oxo-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadec-13-en-3-yl acetate
3,9,22,23-tetrahydroxy-1,5,20-trimethyl-6-(5-oxo-2h-furan-3-yl)-11,17,19,24-tetraoxaheptacyclo[12.12.0.0²,¹⁰.0⁵,⁹.0¹⁰,¹².0¹⁶,²⁵.0¹⁸,²³]hexacosan-4-one
6-(acetyloxy)-7-[(acetyloxy)methyl]-7-hydroxy-4-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
(2s,3r,4s,5r,6s)-3,4,5-trihydroxy-6-[5-hydroxy-2-(3-hydroxy-5-pentylphenoxycarbonyl)-3-pentylphenoxy]oxane-2-carboxylic acid
methyl (2r)-2-[(1s,2r,6r,7r,10r,11s,12s,14s,15r,16r)-14-(acetyloxy)-6-(furan-3-yl)-15,16-dihydroxy-7,11,13,13-tetramethyl-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-12-yl]-2-hydroxyacetate
3,5a-dimethyl-2-oxo-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-6-yl 2-(4-hydroxyphenyl)acetate
(1's,2r,3's,6's,8's,12'r,14's,15'r,18'r,19'e,21'e,25's,26'r)-6',15'-dihydroxy-18'-[(1s)-1-hydroxyethyl]-5',14',26'-trimethyl-2',10',13',17',24'-pentaoxaspiro[oxirane-2,27'-pentacyclo[23.2.1.0³,⁸.0⁸,²⁶.0¹²,¹⁴]octacosane]-4',19',21'-triene-11',23'-dione
12,15,25-trihydroxy-9,9,21,24,26-pentamethyl-4,8,19,23,29-pentaoxaoctacyclo[13.13.1.0¹,¹³.0³,⁷.0³,¹⁰.0¹⁶,²⁶.0¹⁷,²⁴.0¹⁸,²²]nonacosane-5,14,20-trione
(2r)-1-(2-hydroxy-3,5-dimethyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-{[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-2-methylbutan-1-one
(1'r,3'r,6'r,8'r,12's,14'r,15's,18'r,19'e,21'z,25'r,26's)-6',15'-dihydroxy-18'-[(1r)-1-hydroxyethyl]-5',14',26'-trimethyl-2',10',13',17',24'-pentaoxaspiro[oxirane-2,27'-pentacyclo[23.2.1.0³,⁸.0⁸,²⁶.0¹²,¹⁴]octacosane]-4',19',21'-triene-11',23'-dione
methyl (1r,9s,11s,14z,15s,17s,19r)-14-ethylidene-19-[(3,4,5-trimethoxybenzoyloxy)methyl]-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
C31H34N2O8 (562.2315044000001)
methyl 2-[14-(acetyloxy)-6-(furan-3-yl)-15,16-dihydroxy-7,11,13,13-tetramethyl-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-12-yl]-2-hydroxyacetate
(1r,3s,7r,8r,10r,11s,12s,14r,15r,18r)-7-{[(2s,3r,4s,6r)-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-8,12,18-trihydroxy-10,14-dimethyl-15-(5-oxo-2h-furan-3-yl)-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-5-en-13-one
3-(2-{3-hydroxy-4-[(4-hydroxyphenyl)methyl]phenyl}ethyl)-2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol
(2r)-1-[2-hydroxy-3,5-dimethyl-4,6-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phenyl]-2-methylbutan-1-one
6-(acetyloxy)-4-({[3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-hydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
3-(2-{2-hydroxy-5-[(4-hydroxyphenyl)methyl]phenyl}ethyl)-2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol
3-(2-{3-hydroxy-5-[(4-hydroxyphenyl)methyl]phenyl}ethyl)-2,4-bis[(4-hydroxyphenyl)methyl]-5-methoxyphenol
(3e,5s)-3-[(2e,4e,6e)-1-hydroxy-7-[(1s,6s)-6-[(1e,3e,5e)-7-hydroxy-7-[(3z,5s)-2-hydroxy-5-(hydroxymethyl)-4-oxo-5h-pyrrol-3-ylidene]hepta-1,3,5-trien-1-yl]cyclohex-2-en-1-yl]hepta-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione
C31H34N2O8 (562.2315044000001)